Disability Reduction Is a Twist in Negative BTKi RRMS Trial

These data rule out the study hypothesis that a BTKi offers greater protection against relapse than a commonly used immunomodulator.
MDedge News

source https://www.medscape.com/s/viewarticle/disability-reduction-twist-negative-btki-rrms-trial-2024a1000hab?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?